Get the Daily Brief
Latest Biotech News
AI-Driven Antibiotic Design Yields Novel Compounds Against Resistant Bacteria
Researchers at MIT utilized generative artificial intelligence to design structurally novel antibiotics targeting drug-resistant Neisseria gonorrhoeae and MRSA. Screening millions of AI-generated...
Human Embryo Implantation Captured in Real Time with 3D Imaging
For the first time, researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital recorded real-time, three-dimensional images and videos of a human embryo implanting...
Eli Lilly Raises Drug Prices in Europe to Lower US Costs Amid Political Pressure
Eli Lilly announced significant price hikes for its weight-loss drug Mounjaro in the United Kingdom, increasing the list price by approximately 170%. This move aligns with the Trump...
Elysium Therapeutics Develops Longer-Lasting Opioid Overdose Antidote
Elysium Therapeutics is advancing a novel rescue agent designed to address the problem of fentanyl rebound, or re-narcotization, after opioid overdose. Current opioid antagonists like naloxone...
Study Uncovers Estrogen’s Protective Role Against Acute Kidney Injury in Females
German researchers resolved a longstanding question regarding the sex disparity in susceptibility to acute kidney injury (AKI). Their study demonstrated that estrogen exerts a protective effect in...
Breakthrough in Lung Cancer Therapy Using Precision Nanobody Technology
Researchers at Korea Research Institute of Bioscience and Biotechnology developed a nanobody-based therapy enabling highly selective targeting of lung cancer cells. This technology offers...
Mount Sinai Continues as Official Medical Provider for US Open Tennis
Mount Sinai Health System marks its 13th consecutive year serving as the official hospital and medical services provider for the US Open Tennis Championships. The partnership reinforces Mount...
Bionano Genomics Reports Revenue Decline Despite Product Sales Growth
Bionano Genomics reported a 13% year-over-year decline in total revenues for Q2 2025, totaling $6.7 million driven primarily by a 67% drop in service revenues despite a 3% decrease in product...
AI Designs Novel Antibiotics for Drug-Resistant Infections
Researchers at MIT have leveraged generative artificial intelligence (AI) to design new antibiotics targeting difficult infections caused by drug-resistant Neisseria gonorrhoeae and...
FDA Approves Precigen's Gene Therapy for Rare Respiratory Disease
The U.S. Food and Drug Administration (FDA) granted full and rapid approval to Precigen Inc.'s gene therapy Papzimeos (zopapogene imadenovec) for treating adults with recurrent respiratory...
Breakthrough Imaging Captures Human Embryo Implantation In Real Time
Researchers at the Institute for Bioengineering of Catalonia, collaborating with Dexeus University Hospital, have for the first time captured three-dimensional, real-time images and videos of...
Eli Lilly's Strategy to Raise Drug Prices in Europe
Eli Lilly announced it will significantly increase the list prices of its weight-loss drug Mounjaro across European markets, including a 170% hike in the UK. This move aligns with the Trump...
Biopharma Financing Surges Despite IPO Drought
Biopharma deal activity outside M&As has surged to record levels in the first seven months of 2025, reaching $164 billion, reflecting strong investment despite a continuing drought in IPOs to...
Schrödinger Discontinues CDC7 Inhibitor After Patient Deaths
Schrödinger has halted development of its CDC7 inhibitor SGR-2921, an experimental cancer drug, following two patient deaths in a Phase I trial involving acute myeloid leukemia (AML) and high-risk...
Immune-Stimulating Antibody Shows Promise in Early Cancer Trial
A Phase 1 clinical study published in Cancer Cell highlights a novel Fc-optimized CD40 agonistic antibody delivered intratumorally with promising efficacy in metastatic cancer patients. Among 12...
Advanced AI Tools Revolutionize Drug Discovery and Disease Research
Cutting-edge advances in artificial intelligence are transforming biotechnology research workflows. Innovations include a new technology accelerating biological data generation for AI training...
Neural Prosthetic Decodes Inner Speech for Communication
Neuroscientists have developed an innovative brain-computer interface (BCI) that enables communication through decoding imagined speech. Unlike traditional BCIs requiring attempted speech, this...
FDA Grants Full Approval to Precigen's Gene Therapy for Rare Respiratory Disease
The U.S. Food and Drug Administration (FDA) has granted a swift, full approval to Precigen Inc.'s gene therapy, Papzimeos (zopapogene imadenovec), for treating adults with recurrent respiratory...
Pfizer's Sickle Cell Drug Candidate Falters in Phase 3 Trial
Pfizer announced that inclacumab, a sickle cell disease drug candidate acquired from Global Blood Therapeutics, failed to meet its primary endpoint in a Phase 3 clinical study. The candidate did...
Elysium Therapeutics Develops Longer-Lasting Opioid Overdose Antidote
Elysium Therapeutics is advancing a novel therapeutic approach to address opioid overdose through its Synthetic Opioid Overdose Prevention and Reversal (SOOPR) program. The investigational...